SELLEST OSAST

Inglise
Ameerika Ühendriigid

TRANSKRIBEERI 🔗

OTSI VARASEMAID OSASID

Otsi kanali Pharma and BioTech Daily viimaseid osasid.

MUUD EPISOOD SELLES PODCASTIS

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling stories that highlight the dynamic nature of the industry, marked by strategic acquisitions, groundbreaking research, and …
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of exciting advancements and strategic shifts reshaping the landscape of drug development and patient care. A noteworthy collaboration …
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most compelling stories shaping the industry. Let's begin with GSK's bold move to expand its biologics capabiliti…
Full Lp(a)HORIZON results at AHA show Novartis' pelacarsen cut Lp(a) by 78 percent with no cardiovascular benefit, as the FDA heads into a crowded month of decisions on ivonescimab, deramiocel and povetacicept. Also: Mineralys' lorundrostat holds its effect at 48 weeks, Sarepta's new…
Vir Biotechnology reports a pivotal Phase 3 win in chronic hepatitis delta, and argenx agrees to buy Unnatural Products for up to 1.15 billion dollars to add oral macrocyclic peptides. Also: TG Therapeutics raises Briumvi guidance, Xenon's azetukalner filing and X-NOVA2 timing, and Atea's…
Vastutamatussäte: Sellele lehele manustatud taskuhäälingusaade ja kunstiteosed pärinevad Pharma and BioTech News-lt, mis on selle omaniku omand ja ei ole seotud ettevõttega Listen Notes, Inc.